A Radiomics–Clinical Nomogram for Pre-Treatment Prediction of Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer
Diagnostics · 23.03.2026 · 16 (6) · 945
DOI: 10.3390/diagnostics16060945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diagnostics, online erschienen am 23.03.2026. Verfasst von Qianzheng Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College of Nanjing Medical University, Nanjing 211166, China. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Jiangsu Province Science and Education Capacity Enhancement Project, Jiangsu Province Science and Education Capacity Enhancement Project.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To develop and evaluate a nomogram integrating radiomic features from contrast-enhanced CT with clinical variables for pre-treatment predictions of the response to neoadjuvant therapy (NAT) in locally advanced gastric cancer (LAGC).
Methods
In this retrospective multicenter study, 183 LAGC patients from the First Affiliated Hospital of Nanjing Medical University (2014–2023) were included. Radiomic features were extracted from manually delineated pre-treatment CT regions of interest. A machine learning-based predictive model combining radiomic scores and clinical data was constructed. Model performance was assessed using receiver operating characteristic (ROC) analysis, calibration curves, and decision curve analysis (DCA).
Results
Multivariate analysis identified the radiomic score, preoperative N stage, and neoadjuvant regimen as independent predictors of NAT responses (all p < 0.05). The integrated nomogram achieved an area under the ROC curve of 0.807 and showed a moderate net benefit in DCA compared with the radiomics-only model.
Conclusions
The radiomics–clinical nomogram demonstrates moderate predictive performance for pre-treatment stratification of NAT responses in LAGC. These findings are exploratory and hypothesis-generating, and further validation in independent cohorts is required before clinical application.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Clinical Medical College of Nanjing Medical University, Nanjing 211166, China.
- Department of Radiology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
- Department of General Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Förderung
- the Jiangsu Province Science and Education Capacity Enhancement Project
- Jiangsu Province Science and Education Capacity Enhancement Project
Zitieren
APA
Zhou, Q., Xu, J., Li, Q., Li, F., & Xu, H. (2026). A Radiomics–Clinical Nomogram for Pre-Treatment Prediction of Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer. Diagnostics, 16(6), 945. https://doi.org/10.3390/diagnostics16060945
Vancouver
Zhou Q, Xu J, Li Q, Li F, Xu H. A Radiomics–Clinical Nomogram for Pre-Treatment Prediction of Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer. Diagnostics. 2026;16(6):945. doi:10.3390/diagnostics16060945
BibTeX
@article{Zhou2026,
author = {Zhou, Qianzheng and Xu, Jun and Li, Qiong and Li, Fengyuan and Xu, Hao},
title = {A Radiomics–Clinical Nomogram for Pre-Treatment Prediction of Neoadjuvant Chemotherapy Response in Locally Advanced Gastric Cancer},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {6},
pages = {945},
doi = {10.3390/diagnostics16060945}
}
EUVIMED